130 related articles for article (PubMed ID: 23510307)
1. Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse.
Leishman E; Kokesh KJ; Bradshaw HB
Ann N Y Acad Sci; 2013 Apr; 1282():25-38. PubMed ID: 23510307
[TBL] [Abstract][Full Text] [Related]
2. Lipid signaling and synaptic plasticity.
Sang N; Chen C
Neuroscientist; 2006 Oct; 12(5):425-34. PubMed ID: 16957004
[TBL] [Abstract][Full Text] [Related]
3. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
4. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
Basavarajappa BS; Hungund BL
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
[TBL] [Abstract][Full Text] [Related]
5. A perspective for understanding the modes of juvenile hormone action as a lipid signaling system.
Wheeler DE; Nijhout HF
Bioessays; 2003 Oct; 25(10):994-1001. PubMed ID: 14505366
[TBL] [Abstract][Full Text] [Related]
6. Genomic insights into mediator lipidomics.
Hla T
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):197-209. PubMed ID: 16099404
[TBL] [Abstract][Full Text] [Related]
7. Lipidomic analysis of signaling pathways.
Wakelam MJ; Pettitt TR; Postle AD
Methods Enzymol; 2007; 432():233-46. PubMed ID: 17954220
[TBL] [Abstract][Full Text] [Related]
8. Lipids as bioeffectors in the immune system.
Cabral GA
Life Sci; 2005 Aug; 77(14):1699-710. PubMed ID: 15950989
[TBL] [Abstract][Full Text] [Related]
9. Shared mechanisms of alcohol and other drugs.
Cruz MT; Bajo M; Schweitzer P; Roberto M
Alcohol Res Health; 2008; 31(2):137-47. PubMed ID: 23584815
[TBL] [Abstract][Full Text] [Related]
10. Receptor mechanisms mediating non-genomic actions of sex steroids.
Boonyaratanakornkit V; Edwards DP
Semin Reprod Med; 2007 May; 25(3):139-53. PubMed ID: 17447204
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation as a possible link between cannabinoids and addiction.
Rodrigues LC; Gobira PH; de Oliveira AC; Pelição R; Teixeira AL; Moreira FA; Campos AC
Acta Neuropsychiatr; 2014 Dec; 26(6):334-46. PubMed ID: 25455257
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-hormone interactions in the regulation of motivational processes.
López HH
Horm Behav; 2010 Jun; 58(1):100-10. PubMed ID: 19819241
[TBL] [Abstract][Full Text] [Related]
13. Interactions between opioids and anabolic androgenic steroids: implications for the development of addictive behavior.
Nyberg F; Hallberg M
Int Rev Neurobiol; 2012; 102():189-206. PubMed ID: 22748831
[TBL] [Abstract][Full Text] [Related]
14. Lipid body function in eicosanoid synthesis: an update.
Bozza PT; Bakker-Abreu I; Navarro-Xavier RA; Bandeira-Melo C
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):205-13. PubMed ID: 21565480
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous cannabinoids in synaptic signaling.
Freund TF; Katona I; Piomelli D
Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
[TBL] [Abstract][Full Text] [Related]
16. Targeted lipidomics: fatty acid amides and pain modulation.
Walker JM; Krey JF; Chen JS; Vefring E; Jahnsen JA; Bradshaw H; Huang SM
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):35-45. PubMed ID: 16099389
[TBL] [Abstract][Full Text] [Related]
17. [Neurobiology of addiction to drugs of abuse].
Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
[TBL] [Abstract][Full Text] [Related]
18. Lipid mediators regulating pain sensitivity.
Malan TP; Porreca F
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):123-30. PubMed ID: 16099397
[TBL] [Abstract][Full Text] [Related]
19. Regulator of G protein-signaling proteins and addictive drugs.
Traynor J
Ann N Y Acad Sci; 2010 Feb; 1187():341-52. PubMed ID: 20201861
[TBL] [Abstract][Full Text] [Related]
20. Synaptic effects of cannabinoids: complexity, behavioral effects, and potential clinical implications.
Benarroch EE
Neurology; 2014 Nov; 83(21):1958-67. PubMed ID: 25339212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
